Supernus Pharmaceuticals | SUPN - Ativos





Ativos Alterar Data
Abbott USD 108.25B 968M 2026-09
ANI Pharmaceuticals USD 1.57B 73.55M 2026-09
Aurora Cannabis CAD 620.88M 19.79M 2026-06
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Canopy Growth CAD 1.1B 14.81M 2026-06
Cara Therapeutics USD 25.82M 6.26M 2026-03
Corcept Therapeutics USD 1.03B 145.32M 2026-09
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 148.07B 5.79B 2026-09
Novo Nordisk DKK 594.94B 35.72B 2026-06
Pacira USD 34.68B 33.44B 2026-09
Perrigo USD 7.48B 124.6M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Supernus Pharmaceuticals USD 1.4B 30.42M 2026-09
United Therapeutics USD 7.03B 186M 2026-09
Xeris Pharmaceuticals USD 423.22M 11.31M 2026-09